226 related articles for article (PubMed ID: 19144661)
1. Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.
Bennett JM; Orazi A
Haematologica; 2009 Feb; 94(2):264-8. PubMed ID: 19144661
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
4. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
Varma N; Varma S; Marwaha N; Garewal G
Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
[TBL] [Abstract][Full Text] [Related]
5. Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431.
Mast KJ; Taub JW; Alonzo TA; Gamis AS; Mosse CA; Mathew P; Berman JN; Wang YC; Jones HM; Campana D; Coustan-Smith E; Raimondi SC; Hirsch B; Hitzler JK; Head DR
Arch Pathol Lab Med; 2020 Apr; 144(4):466-472. PubMed ID: 31429606
[TBL] [Abstract][Full Text] [Related]
6. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia.
Kitagawa M; Kamiyama R; Kasuga T
Hum Pathol; 1993 Apr; 24(4):359-63. PubMed ID: 8098317
[TBL] [Abstract][Full Text] [Related]
7. Issues in the pathology of the myelodysplastic syndromes.
Kampmeier P; Anastasi J; Vardiman JW
Hematol Oncol Clin North Am; 1992 Jun; 6(3):501-22. PubMed ID: 1613003
[TBL] [Abstract][Full Text] [Related]
8. [CME myelodysplasia - a frequent hematologic neoplasia in the elderly].
Schleiffenbaum BE
Praxis (Bern 1994); 2014 May; 103(11):617-27. PubMed ID: 24846886
[No Abstract] [Full Text] [Related]
9. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
10. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
Rosati S; Anastasi J; Vardiman J
Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
[No Abstract] [Full Text] [Related]
11. The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia.
Lorand-Metze I; Meira DG; Lima CS; Vassallo J; Metze K
Haematologica; 1999 Jun; 84(6):564-5. PubMed ID: 10366807
[No Abstract] [Full Text] [Related]
12. [A case of hypoplastic acute leukemia which transformed naturally from hypercellular bone marrow to hypocellular with reference to the atypical aplastic anemia (author's transl)].
Nishio A; Nakanishi S; Kitamura M; Ashizawa H; Hamami T; Nakata T; Hosoda M; Haruyama H; Katsuki A; Sugishima K; Ijichi H; Isemura T
Rinsho Ketsueki; 1981 Nov; 22(11):1743-50. PubMed ID: 6951065
[No Abstract] [Full Text] [Related]
13. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
15. [Myelodysplastic syndrome--a retrospective study of 38 patients].
Schrappe-Bächer M; Steffen HM; Maier M; Bernards P; Hoeffken A; Fätkenheuer G
Med Klin (Munich); 1990 Sep; 85(9):511-6. PubMed ID: 2233608
[TBL] [Abstract][Full Text] [Related]
16. Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
Schemenau J; Baldus S; Anlauf M; Reinecke P; Braunstein S; Blum S; Nachtkamp K; Neukirchen J; Strup C; Aul C; Haas R; Gattermann N; Germing U
Eur J Haematol; 2015 Sep; 95(3):181-9. PubMed ID: 25600827
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium.
Nakano TA; Lau BW; Dickerson KE; Wlodarski M; Pollard J; Shimamura A; Hofmann I; Sasa G; Elghetany T; Cada M; Dror Y; Ding H; Allen SW; Hanna R; Campbell K; Olson TS
Pediatr Blood Cancer; 2020 Oct; 67(10):e28652. PubMed ID: 32779892
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of aplastic anemia and myelodysplastic syndrome.
Paquette RL
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):153-61. PubMed ID: 12380966
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndromes: preleukemic or early leukemic conditions?
Dörmer P
Haematol Blood Transfus; 1990; 33():3-7. PubMed ID: 2323634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
